WOS: 000270557900011PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium tuberculosis strains isolated from a tertiary care hospital in Izmir. A total of 67 M. tuberculosis strains (33 multidrug-resistant [MDR] and 34 non-MDR) were isolated and identified by the Tuberculosis Laboratory, Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Ege University. The activity of linezolid was studied by the standard agar proportion method. For all of the strains, the MIC range was 0.06-1 mg/L, and the MIC50 and MIC90 values were 0.5 mg/L. No differences were observed between the MDR and non-MDR isolates. In general, linezolid was found to be effective for both the non-MDR and MDR M. tuberculosis stra...
Tuberculosis is a severe, infectious disease caused by Mycobacterium tuberculosis. The aim of this r...
Introduction: Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant ...
Contains fulltext : 138269.pdf (Publisher’s version ) (Closed access
PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium tuberculosis strain...
WOS: 000265293000006Objective: The aim of our study was to determine susceptibility of linezolid to ...
• Objective: The aim of our study was to determine susceptibility of linezolid to multi-resistant My...
WOS: 000251225500006PubMed ID: 18080676The activity of linezolid (Pfizer, USA) was tested by broth m...
Objectives: In vitro studies have shown good activity of linezolid against Mycobacterium tuberculosi...
Item does not contain fulltextSusceptibility of clinical Mycobacterium tuberculosis isolates to PNU-...
Background. Linezolid is a new antibiotic with activity against Mycobacterium tuberculosis in vitro ...
Susceptibility of clinical Mycobacterium tuberculosis isolates to PNU-100480 and linezolid was evalu...
The management of multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) pre...
WOS: 000294274700020Aim: To investigate the in vitro activity of linezolid and ofloxacin in combinat...
Aim: To investigate the in vitro activity of linezolid and ofloxacin in combination with first-line ...
The aim of this study is to compare the in vitro activity and minimal inhibitory concentration (MIC)...
Tuberculosis is a severe, infectious disease caused by Mycobacterium tuberculosis. The aim of this r...
Introduction: Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant ...
Contains fulltext : 138269.pdf (Publisher’s version ) (Closed access
PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium tuberculosis strain...
WOS: 000265293000006Objective: The aim of our study was to determine susceptibility of linezolid to ...
• Objective: The aim of our study was to determine susceptibility of linezolid to multi-resistant My...
WOS: 000251225500006PubMed ID: 18080676The activity of linezolid (Pfizer, USA) was tested by broth m...
Objectives: In vitro studies have shown good activity of linezolid against Mycobacterium tuberculosi...
Item does not contain fulltextSusceptibility of clinical Mycobacterium tuberculosis isolates to PNU-...
Background. Linezolid is a new antibiotic with activity against Mycobacterium tuberculosis in vitro ...
Susceptibility of clinical Mycobacterium tuberculosis isolates to PNU-100480 and linezolid was evalu...
The management of multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) pre...
WOS: 000294274700020Aim: To investigate the in vitro activity of linezolid and ofloxacin in combinat...
Aim: To investigate the in vitro activity of linezolid and ofloxacin in combination with first-line ...
The aim of this study is to compare the in vitro activity and minimal inhibitory concentration (MIC)...
Tuberculosis is a severe, infectious disease caused by Mycobacterium tuberculosis. The aim of this r...
Introduction: Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant ...
Contains fulltext : 138269.pdf (Publisher’s version ) (Closed access